Trajectories of CD4 T‐cell count, CD8 T‐cell count, and CD4 / CD8 ratio in patients with HIV and long‐term virological suppression based on Yunnan HIV cohort
HIV Medicine · 2025
DOI: 10.1111/hiv.13707 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, 2025. Verfasst von Yuanlu Shu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Affiliated Hospital of Infectious Diseases of Kunming Medical University, Kunming, China. Hauptthemen laut MEDLINE: HIV Infections, CD4-CD8 Ratio, CD8-Positive T-Lymphocytes, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: the Major Science and Technology Project of Yunnan Provincial Science and Technology Department, the Talents Project of Yunnan Provincial Science and Technology Department, the Reserve Talents Project of Yunnan Provincial Health Commission.
Abstract (Originalsprache)
Objective
Our objective was to evaluate the trajectory of immunology in patients with HIV with different baseline CD4 T‐cell count strata after antiretroviral therapy (ART) under long‐term viral suppression.
Methods
This was a sub‐analysis focused on patients with virological suppression for at least 5 years after ART. Data were obtained from the Yunnan HIV cohort in China. Patients were categorized according to prespecified baseline CD4 T‐cell counts. The trajectories of CD4 T‐cell count, CD8 T‐cell count, and CD4/CD8 ratio changing over time were fitted using a B‐spline regression model. The Cox proportional hazards regression model was used to assess the association of baseline CD4 T‐cell count with the risk of both immunological responder (IR) and CD4/CD8 ratio normalization.
Results
A total of 2618 patients with a median follow‐up of 7.25 years (interquartile range [IQR] 5.92–8.75) were included. Over a period of 12 years, the mean CD4 T‐cell count remained above 500 cells/μL in all groups. The mean CD4/CD8 ratio was solely normalized in patients whose baseline CD4 T‐cell counts were above 350 cells/μL. Patients with higher baseline CD4 T‐cell counts showed higher risks of both IR and CD4/CD8 ratio normalization than those with the lowest (all p trend
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Affiliated Hospital of Infectious Diseases of Kunming Medical University, Kunming, China.
- Department of Laboratory Medicine, Yunnan Provincial Infectious Disease Hospital, Kunming, China.
ORCID-Profile: Xingqi Dong
Förderung
- the Major Science and Technology Project of Yunnan Provincial Science and Technology Department
- the Talents Project of Yunnan Provincial Science and Technology Department
- the Reserve Talents Project of Yunnan Provincial Health Commission
- the School-level Scientific Research Project of Jishou University
Zitieren
APA
Shu, Y., Zhang, M., Li, J., Deng, X., Liu, J., Yang, C., & Dong, X. (2025). Trajectories of CD4 T‐cell count, CD8 T‐cell count, and CD4 / CD8 ratio in patients with HIV and long‐term virological suppression based on Yunnan HIV cohort. HIV Medicine. https://doi.org/10.1111/hiv.13707
Vancouver
Shu Y, Zhang M, Li J, Deng X, Liu J, Yang C, et al. Trajectories of CD4 T‐cell count, CD8 T‐cell count, and CD4 / CD8 ratio in patients with HIV and long‐term virological suppression based on Yunnan HIV cohort. HIV Medicine. 2025. doi:10.1111/hiv.13707
BibTeX
@article{Shu2025,
author = {Shu, Yuanlu and Zhang, Mi and Li, Jianjian and Deng, Xuemei and Liu, Jiafa and Yang, Cuixian and Dong, Xingqi},
title = {Trajectories of CD4 T‐cell count, CD8 T‐cell count, and CD4 / CD8 ratio in patients with HIV and long‐term virological suppression based on Yunnan HIV cohort},
journal = {HIV Medicine},
year = {2025},
doi = {10.1111/hiv.13707}
}
EUVIMED